EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sympathetic Nervous System and Atherosclerosis

Yutang Wang iD, Jack Anesi, Michelle C Maier iD, Mark A Myers iD, Ernesto Oqueli, Christopher G Sobey iD, Grant R Drummond, Kate M Denton iD

International Journal of Molecular Sciences · 23.08.2023 · 24 (17) · 13132

DOI: 10.3390/ijms241713132 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.08.2023. Verfasst von Yutang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Life Science, Institute of Innovation, Science and Sustainability, Federation University Australia, Ballarat, VIC 3350, Australia. Hauptthemen laut MEDLINE: Atherosclerosis, Heart Failure, Hypercholesterolemia. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, National Health and Medical Research Council of Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is characterized by the narrowing of the arterial lumen due to subendothelial lipid accumulation, with hypercholesterolemia being a major risk factor. Despite the recent advances in effective lipid-lowering therapies, atherosclerosis remains the leading cause of mortality globally, highlighting the need for additional therapeutic strategies. Accumulating evidence suggests that the sympathetic nervous system plays an important role in atherosclerosis. In this article, we reviewed the sympathetic innervation in the vasculature, norepinephrine synthesis and metabolism, sympathetic activity measurement, and common signaling pathways of sympathetic activation. The focus of this paper was to review the effectiveness of pharmacological antagonists or agonists of adrenoceptors (α1, α2, β1, β2, and β3) and renal denervation on atherosclerosis. All five types of adrenoceptors are present in arterial blood vessels. α1 blockers inhibit atherosclerosis but increase the risk of heart failure while α2 agonism may protect against atherosclerosis and newer generations of β blockers and β3 agonists are promising therapies against atherosclerosis; however, new randomized controlled trials are warranted to investigate the effectiveness of these therapies in atherosclerosis inhibition and cardiovascular risk reduction in the future. The role of renal denervation in atherosclerosis inhibition in humans is yet to be established.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisHeart FailureHypercholesterolemiaHumansSympathetic Nervous SystemReceptors, AdrenergicLipids

Stichwörter der Autor:innen

alpha blockeratherosclerosisbeta blockerblood vesselrenal denervationsympathetic activity

Substanzen

Receptors, AdrenergicLipids

Autor:innen und Institutionen

  • Discipline of Life Science, Institute of Innovation, Science and Sustainability, Federation University Australia, Ballarat, VIC 3350, Australia.
  • Cardiology Department, Grampians Health Ballarat, Ballarat, VIC 3350, Australia.
  • School of Medicine, Faculty of Health, Deakin University, Geelong, VIC 3216, Australia.
  • Centre for Cardiovascular Biology and Disease Research, Department of Microbiology, Anatomy, Physiology & Pharmacology, School of Agriculture, Biomedicine & Environment, La Trobe University, Melbourne, VIC 3086, Austral…
  • Department of Physiology, Monash University, Melbourne, VIC 3800, Australia.
  • Cardiovascular Disease Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia.

ORCID-Profile: Yutang Wang, Michelle C Maier, Mark A Myers, Christopher G Sobey, Kate M Denton

Förderung

  • National Health and Medical Research Council
  • National Health and Medical Research Council of Australia

Zitieren

APA

Wang, Y., Anesi, J., Maier, M. C., Myers, M. A., Oqueli, E., Sobey, C. G., Drummond, G. R., & Denton, K. M. (2023). Sympathetic Nervous System and Atherosclerosis. International Journal of Molecular Sciences, 24(17), 13132. https://doi.org/10.3390/ijms241713132

Vancouver

Wang Y, Anesi J, Maier MC, Myers MA, Oqueli E, Sobey CG, et al. Sympathetic Nervous System and Atherosclerosis. International Journal of Molecular Sciences. 2023;24(17):13132. doi:10.3390/ijms241713132

BibTeX
@article{Wang2023,
  author = {Wang, Yutang and Anesi, Jack and Maier, Michelle C and Myers, Mark A and Oqueli, Ernesto and Sobey, Christopher G and Drummond, Grant R and Denton, Kate M},
  title = {Sympathetic Nervous System and Atherosclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {17},
  pages = {13132},
  doi = {10.3390/ijms241713132}
}
Kostenlos starten →